Volume 8 Issue 46
Published - 14:00 UTC 08:00 EST 15-Feb-2006 
Next Update - 14:00 UTC 08:00 EST 16-Feb-2006

Editor: Susan K. Boyer, RN
Vidyya.
All rights reserved.

We subscribe to the HONcode principles. Verify here.

  

 


Daily diet of grapefruit minimizes risk factor for heart disease

Heart disease patients who eat one grapefruit daily can significantly reduce the levels of cholesterol in their blood in comparison to patients who do not eat the fruit, a new study has found. Chronic high blood cholesterol is a major risk factor for heart disease. more  

Reduce bloating and excess gas with a common antibiotic

In the first study of its kind, researchers discovered that rifaximin, an antibiotic used to treat diarrhea, is an effective treatment for abdominal bloating and flatulence, including in irritable bowel syndrome (IBS) patients. This research is published in the February issue of The American Journal of Gastroenterology. more

New targeted treatment for brain tumors shows promise in pre-clinical models

Gliomas are the most common primary brain tumors, and also one of the most complicated cancers to treat. Currently, treatment options such as surgery, radiation and chemotherapy are only marginally beneficial and present significant risks for patients, including loss of physical and cognitive abilities. But, a new study published today in Clinical Cancer Research found that treatment with a novel monoclonal antibody (mAb) L2G7 inhibited the growth of glioma cells, induced glioma regression within the brain and prolonged survival a finding that could be translated into human trials as early as next year. more  

Healthy pre-term infants show reduced lung function

Tests of healthy preterm infants younger than 12 weeks of age show prematurity to be independently associated with reduced lung function. Predictors of this reduced expiratory flow during the first months of life include male sex, low gestational age and increased weight gain. more

New compound may protect against liver cancer 

Researchers have identified a new compound called CDDO-Im that protects against the development of liver cancer in laboratory animals. The compound appears to stimulate the enzymes that remove toxic substances from the cells, thereby increasing the cells' resistance to cancer-causing toxins. The National Institute of Environmental Health Sciences and the National Cancer Institute, agencies of the federal National Institutes of Health, provided funding to researchers at the Johns Hopkins Bloomberg School of Public Health for the two-year study. more

Botox could help target resistant tumors for treatment  

The cosmetic treatment Botox may have a new use as an adjuvant to cancer therapy, providing an open door for chemotherapy and radiation treatments, according to a study published in the Feb. 15 issue of Clinical Cancer Research. more

Study with smokers shows vitamins combine for benefits

A new study has found that supplements of vitamin C can largely stop the serious depletion of vitamin E that occurs in smokers, demonstrating for the first time in humans a remarkable interaction between these two antioxidants as they work together. more

 

Heart disease patients who eat one grapefruit daily can significantly reduce the levels of cholesterol in their blood in comparison to patients who do not eat the fruit